Thomas Illmer

11.4k citations
101 papers · 5.2k · 2 hit papers · h-index 32

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 0.5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 41
    • Chronic Myeloid Leukemia Treatments 26
    • Hematopoietic Stem Cell Transplantation 15
    • Chronic Lymphocytic Leukemia Research 17
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 6

Thomas Illmer

97 papers receiving 5.1k citations

Thomas Illmer's Hit Papers

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) 2006 · 509 citations
5090+8+16Years since publication4008001.2k

Peers

Thomas Illmer
Comparison fields: 5 of 110
  • Hematology 3.1k
  • Genetics 1.6k
  • Clinical Biochemistry 285
  • Oncology 1.1k
  • Cancer Research 464
Replace Stanley L. Schrier with:
Stanley L. Schrier United States
Thomas Luther Germany
Wilson I. Gonsalves United States
Florence Toti France
David J. Salant United States
Markus Schaich Germany
Franco Ferrario Italy
Marek Z. Wojtukiewicz Poland
Heinz Gisslinger Austria
Jun Peng China
Thomas Illmer relative to Stanley L. Schrier United States Stanley L. Schrier's profile →
Citations per field
00.5×4.5×
Stanley L. Schrier · 1×
Citations per year

Countries citing papers authored by Thomas Illmer

Since Specialization
Citations

This map shows the geographic impact of Thomas Illmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Illmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Illmer more than expected).

Fields of papers citing papers by Thomas Illmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Illmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Illmer. The network helps show where Thomas Illmer may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Illmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Illmer Line = papers co-authored together Thomas Illmer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Hit paper breakdown →
20021273
2
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Hit paper breakdown →
2006509
3 1997309
4 2004242
5 2008232
6
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
2002213
7 1997185
8 2005130
9 2003115
10 2009115
11 2008111
12 200291
13 200991
14 200778
15 201869
16 200969
17 200462
18 200759
19 200457
20 200055

About Thomas Illmer

Thomas Illmer is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Immunology, having authored 101 papers that have together received 5.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (41 papers), Chronic Myeloid Leukemia Treatments (26 papers), Chronic Lymphocytic Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (15 papers), Acute Lymphoblastic Leukemia research (8 papers), Drug Transport and Resistance Mechanisms (8 papers), Retinoids in leukemia and cellular processes (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). The work is most often cited by research in Hematology (3.1k citations), Genetics (1.6k citations), Clinical Biochemistry (285 citations), Oncology (1.1k citations) and Cancer Research (464 citations). Thomas Illmer has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Gerhard Ehninger, Markus Schaich, Christian Thiede, Martin Bornhäuser, Christine Steudel, Ulrike Schäkel, Uwe Platzbecker, Brigitte Mohr, Andreas Neubauer and Martin Wermke. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Leukemia and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact